Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Kashinath G Yadalam M D
EIR
•Kashinath G Yadalam M D•October 6, 2011

Kashinath G Yadalam M D – FDA EIR, Oct 6, 2011

Record Details

An FDA inspection of clinical investigator Dr. Kashinath G. Yadalam, operating as Lake Charles Clinical Trials, L.L.C., was conducted from September 26 to October 6, 2011. The inspection assessed adherence to Good Clinical Practice (GCP), Human Subject Protection (HSP), and Financial Disclosure regulations, aligning with Compliance Program 7348.811 for Clinical Investigators.

Key violations identified on an FDA-483 included a failure to maintain adequate and accurate case histories. This manifested as insufficient documentation of the investigator's observations during inpatient hospitalizations and discrepancies between non-study and study medication records, leading to inaccurate medical histories. A critical finding was the enrollment of an ineligible subject due to prior experimental drug treatment within a prohibited timeframe, highlighting an inadequate system to prevent such protocol deviations. Other issues discussed included a general lack of investigator progress notes for outpatient evaluations, failure to explicitly identify certain subject populations in IRB submissions, and reliance on subject-reported medical histories over verifiable medical records for eligibility.

In response, Dr. Yadalam implemented new Standard Operating Procedures (SOPs) to improve documentation of investigator oversight for both inpatient and outpatient visits. He also established procedures for obtaining and retaining comprehensive patient medical and study participation histories to prevent future enrollment errors. Dr. Yadalam committed to a full review of existing records, correction of identified discrepancies, and providing a written response to the FDA outlining corrective actions.

Company
Kashinath G Yadalam M D
Inspection date
October 6, 2011
Product type
drugs
Office
New Orleans District Office
People
  • Dana M. Klimavicz (investigator)
  • Kashinath G. Yadalam (recipient)
  • Barbara D. Wright (investigator)
View Company Profile

ID · ddea57c8-9211-4a99-9d93-3d6c45b19df7

Violation Codes3
21 CFR 312.6021 CFR 312.62(b)21 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for Kashinath G Yadalam M D
  • 483 - 2011-10-06October 6, 2011

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kashinath G Yadalam M D
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.